Physician profile
William Joseph Maloney
NPI 1255487500
$11,140,279.91
in general payments reported to CMS, 2019-2025
11 companies · $1.6M in 2025
The $1.6M reported for 2025 was more than what 99% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.3M · 2020: $1.3M · 2021: $1.7M · 2022: $1.9M · 2023: $1.8M · 2024: $1.5M · 2025: $1.6M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $4.8M · Travel and Lodging: $106K · Consulting Fee: $14K · Food and Beverage: $6,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $4,788,225.71 |
| Travel and Lodging | $106,273.16 |
| Consulting Fee | $13,500.00 |
| Food and Beverage | $6,744.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $8,994,718.82 | 2019-2025 | Accolade, Triathlon, Trident |
| Zimmer Biomet Holdings, INC. | $2,047,734.25 | 2019-2023 | Persona |
| Pacira Therapeutics, INC. | $93,926.64 | 2019-2021 | |
| Heron Therapeutics, INC. | $2,392.95 | 2022 | |
| Medical Device Business Services, INC. | $585.63 | 2019-2023 | |
| Onkos Surgical, INC. | $302.08 | 2021-2025 | Eleos Limb Salvage System |
| Djo, LLC | $274.15 | 2021-2024 | Donjoy |
| Davol INC. | $152.28 | 2025 | Channel Drain |
| Smith+Nephew, INC. | $121.43 | 2023 | |
| Depuy Synthes Sales INC. | $71.68 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$60.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Maloney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.